Balanced news tone
News Sentiment
PCK sentiment intelligence
PainChek Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
88/100 classification confidence.
directly relevant articles
high-authority source matches
+15.0% over one week, -11.5% over four weeks, trend inactive, and below fair value.
PainChek Discloses Final Director Interest Following Board Departure
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
PainChek Discloses Final Director Interest Following Board Departure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 04:18
- Source
- The Globe and Mail
PainChek (ASX: PCK) Climbs 15% as Digital Healthcare Stocks Attract Interest
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:23
- Source
- Kalkine
PainChek's (ASX:PCK) New Chair Steps Into Focus as Health-Tech Investors Watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Kalkine
PainChek (ASX:PCK) Updates Governance Structure Amid Ongoing Commercial Expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Kalkine
Health Check: PainChek shares surge after AI innovator’s landmark North American deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 14 Apr 2026 07:00
- Source
- Stockhead
PainChek (ASX:PCK) lands US$5B Sabra REIT, 20,000 beds worth A$1.5m
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stocks Down Under
PainChek unlocks further US market opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- The Australian
Insights: PainChek Ltd (ASX:PCK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Oct 2025 15:55
- Source
- smallcaps.com.au
Should FDA De Novo Clearance for Adult App Prompt a Rethink by PainChek (ASX:PCK) Investors?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Oct 2025 07:00
- Source
- simplywall.st
The Bull Case For PainChek (ASX:PCK) Could Change Following Historic FDA Approval and US Market Entry – Learn Why
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 10 Oct 2025 07:00
- Source
- Market source
Painchek Ltd (PCK) Revenue Breakdown - Main Composition
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2025 18:52
- Source
- Moomoo
PainChek Ltd (ASX:PCK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Sep 2019 08:36
- Source
- intelligentinvestor.com.au
PainChek reveals progress for its pain assessment app in the US
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 May 2018 07:00
- Source
- Proactive financial news
PCK Stock Price and Chart — ASX:PCK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jan 2018 22:22
- Source
- TradingView